APA (7th ed.) Citation

R, C., P, S., R, C., L, D. M., M, C., T, I., . . . Y, W. (2023). mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data. Current neuropharmacology, 21(1), 105. https://doi.org/10.2174/1570159X20666220509160511

Chicago Style (17th ed.) Citation

R, Celli, et al. "MGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data." Current Neuropharmacology 21, no. 1 (2023): 105. https://doi.org/10.2174/1570159X20666220509160511.

MLA (9th ed.) Citation

R, Celli, et al. "MGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data." Current Neuropharmacology, vol. 21, no. 1, 2023, p. 105, https://doi.org/10.2174/1570159X20666220509160511.